Trials / Unknown
UnknownNCT03042260
Prophylactic Trimethoprim/Sulfamethoxazole to Prevent Severe Infections in Patients With Lupus Erythematous
Prophylactic Trimethoprim-Sulfamethoxazole for the Prevention of Serious Infections in Patients With Systemic Lupus Erythematosus: a Randomized Placebo Controlled Trial
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 310 (estimated)
- Sponsor
- Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether trimethoprim/sulfamethoxazole is effective in preventing serious infectious complications (those that require hospitalization or lead to death) in patients with lupus erythematosus that receive intermediate or high dose steroids.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Trimethoprim-Sulfamethoxazole | oral tablets, 3 times a week, for a minimum of 6 months and maximum of 1 year. |
| DRUG | Placebo Oral Tablet | oral tablets, 3 times a week, for a minimum of 6 months and maximum of 1 year. |
Timeline
- Start date
- 2017-03-01
- Primary completion
- 2021-02-01
- Completion
- 2021-08-01
- First posted
- 2017-02-03
- Last updated
- 2019-02-27
Locations
1 site across 1 country: Mexico
Source: ClinicalTrials.gov record NCT03042260. Inclusion in this directory is not an endorsement.